Literature DB >> 15574357

Role of protein kinases in neurodegenerative disease: cyclin-dependent kinases in Alzheimer's disease.

Edward A Monaco1, Mary Lou Vallano.   

Abstract

Cyclin-dependent kinases (Cdks) are serine/threonine kinases that regulate a number of cellular processes including the cell cycle and neuronal differentiation. Accumulating evidence indicates that two distinct Cdk pathways may have a role in the neuronal loss that is responsible for Alzheimer's disease. One pathway involves the aberrant reactivation of the cell cycle, a process believed to be incompatible with neuronal function. A second involves dysregulation of Cdk5, a member of this kinase family with no known cell cycle functions, but prominently expressed in postmitotic neurons. Reports supporting the involvement of both pathways are plentiful, but the story is not yet complete. In particular, difficulties incorporating the extended latency of AD into model approaches persist. Despite this, the theory that Cdks are involved in the pathogenesis of AD has generated considerable interest.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15574357     DOI: 10.2741/1516

Source DB:  PubMed          Journal:  Front Biosci        ISSN: 1093-4715


  12 in total

1.  Complex regulation of p73 isoforms after alteration of amyloid precursor polypeptide (APP) function and DNA damage in neurons.

Authors:  Samir Benosman; Xiangjun Meng; Yannick Von Grabowiecki; Lavinia Palamiuc; Lucian Hritcu; Isabelle Gross; Georg Mellitzer; Yoichi Taya; Jean-Philippe Loeffler; Christian Gaiddon
Journal:  J Biol Chem       Date:  2011-10-14       Impact factor: 5.157

2.  O-GlcNAc transferase regulates mitotic chromatin dynamics.

Authors:  Kaoru Sakabe; Gerald W Hart
Journal:  J Biol Chem       Date:  2010-08-30       Impact factor: 5.157

3.  A truncated peptide from p35, a Cdk5 activator, prevents Alzheimer's disease phenotypes in model mice.

Authors:  Varsha Shukla; Ya-Li Zheng; Santosh K Mishra; Niranjana D Amin; Joseph Steiner; Philip Grant; Sashi Kesavapany; Harish C Pant
Journal:  FASEB J       Date:  2012-10-04       Impact factor: 5.191

4.  The potential for estrogens in preventing Alzheimer's disease and vascular dementia.

Authors:  James W Simpkins; Evelyn Perez; Xiaofei Wang; Shaohua Yang; Yi Wen; Meharvan Singh
Journal:  Ther Adv Neurol Disord       Date:  2009-01       Impact factor: 6.570

5.  Commentary on "a roadmap for the prevention of dementia II. Leon Thal Symposium 2008." Rationale and recommendations for first evaluating anti-Alzheimer's disease medications in acute brain injury patients.

Authors:  James W Simpkins; Joshua W Gatson; Jane G Wigginton
Journal:  Alzheimers Dement       Date:  2009-03       Impact factor: 21.566

6.  Neuropathological characterization of Lemur tyrosine kinase 2 (LMTK2) in Alzheimer's disease and neocortical Lewy body disease.

Authors:  János Bencze; Máté Szarka; Viktor Bencs; Renáta Nóra Szabó; Máté Smajda; Dag Aarsland; Tibor Hortobágyi
Journal:  Sci Rep       Date:  2019-11-20       Impact factor: 4.379

7.  Lemur Tyrosine Kinase 2 (LMTK2) Level Inversely Correlates with Phospho-Tau in Neuropathological Stages of Alzheimer's Disease.

Authors:  János Bencze; Máté Szarka; Viktor Bencs; Renáta Nóra Szabó; László V Módis; Dag Aarsland; Tibor Hortobágyi
Journal:  Brain Sci       Date:  2020-01-27

8.  Analysis of the Inhibitory Elements in the p5 Peptide Fragment of the CDK5 Activator, p35, CDKR1 Protein.

Authors:  B K Binukumar; Varsha Shukla; Niranjana D Amin; Manju Bhaskar; Suzanne Skuntz; Joseph Steiner; Dirk Winkler; Steven L Pelech; Harish C Pant
Journal:  J Alzheimers Dis       Date:  2015       Impact factor: 4.472

Review 9.  Biological function of Lemur tyrosine kinase 2 (LMTK2): implications in neurodegeneration.

Authors:  János Bencze; Gábor Miklós Mórotz; Woosung Seo; Viktor Bencs; János Kálmán; Christopher Charles John Miller; Tibor Hortobágyi
Journal:  Mol Brain       Date:  2018-04-10       Impact factor: 4.041

10.  Phosphorylation of caspase-9 at Thr125 directs paclitaxel resistance in ovarian cancer.

Authors:  Mi Ran Byun; Jin Woo Choi
Journal:  Oncotarget       Date:  2017-12-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.